Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Amgen Inc.
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Biotech
Market Cap: $158.92B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.37 | 0.99%
Avg Daily Range (30 D): $3.05 | 1.10%
Avg Daily Range (90 D): $3.58 | 1.23%
Institutional Daily Volume
Avg Daily Volume: 4.84M
Avg Daily Volume (30 D): 2.18M
Avg Daily Volume (90 D): 2.26M
Trade Size
Avg Trade Size (Sh.): 134
Avg Trade Size (Sh.) (30 D): 40
Avg Trade Size (Sh.) (90 D): 40
Institutional Trades
Total Inst.Trades: 112,927
Avg Inst. Trade: $6.19M
Avg Inst. Trade (30 D): $29.83M
Avg Inst. Trade (90 D): $34.27M
Avg Inst. Trade Volume: .05M
Avg Inst. Trades (Per Day): 20
Market Closing Trades
Avg Closing Trade: $64.3M
Avg Closing Trade (30 D): $132.94M
Avg Closing Trade (90 D): $166.39M
Avg Closing Volume: 386.65K
   
News
Jun 19, 2025 @ 2:58 PM
Artificial Intelligence (AI) Collaboration, R&D, a...
Source: Researchandmarkets.Com
Jun 17, 2025 @ 1:33 PM
Members of Congress Are Pouring Millions Into Thes...
Source: Neil Rozenbaum
Jun 16, 2025 @ 8:00 PM
Saudia Arabia Introduces Strategic Healthcare Visi...
Source: Riyadh, Kingdom Of Saudi Arabia
Jun 15, 2025 @ 11:30 AM
Eli Lilly Just Made Another Move to Dominate the W...
Source: Prosper Junior Bakiny
Jun 10, 2025 @ 8:53 AM
Rheumatoid Arthritis Global Market Research Report...
Source: Na
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $3.22 $5.27
Diluted EPS $3.2 $5.22
Revenue $ $ 8.15B $ 8.5B
Gross Profit $ $ 5.18B $ 5.19B
Net Income / Loss $ $ 1.73B $ 2.83B
Operating Income / Loss $ $ 1.18B $ 2.05B
Cost of Revenue $ $ 2.97B $ 3.31B
Net Cash Flow $ $ -3163M $ -290M
PE Ratio